✦ LIBER ✦

P84 Response monitoring with positron emission tomography (PET) in patients with advanced non-small-cell lung cancer (NSCLC) treated with bevacizumab and erlotinib: a phase II study

✍ Scribed by A. de Langen; O. Hoekstra; A. Dingemans; H. Groen; V. van den Boogaart; J. Pruijm; P. Kappert; E. Smit

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9174 Phase II study of everolimus plus e

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Role of positron emission tomography (PE

✍ V. Gebbia; U. Ficola; G. Mancuso; Arcara C. La Maddalena 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A phase II study of enzastaurin in combi

✍ Clément-Duchêne, Christelle; Natale, Ronald B.; Jahan, Thierry; Krupitskaya, Yel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB

P-208 A phase II study of J-107088 in pr

✍ Kalmadi, S.R.; Dragnev, K.H.; Lynch, T.J.; Crawford, J.; Xu, Li; Gruia, G.; Riga 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 191 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Results of a phase II study with vinorel

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB